Home › Funds › CX Institutional › JNJ

CX Institutional position in JNJ

JOHNSON & JOHNSON · Health Care

CX Institutional reported holding 64,782 shares of JNJ (JOHNSON & JOHNSON) in its Q3 2026 13F filing — a position valued at US$17.1M, representing 0.46% of its reported portfolio and ranking #48 among its reported holdings. CX Institutional has disclosed JNJ holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)64.78K sh
Reported value held$17.15M
Portfolio Weight0.46%
First reportedQ3 2023
Last changeAdd
Updated2026-10-09

Last updated: 2026-10-09 · Source: SEC EDGAR Form 13F-HR

How CX Institutional's JNJ position evolved

CX Institutional first disclosed a stake in JNJ in Q3 2023 at 34,647 shares (US$5.4M). The position peaked in Q3 2026 at 64,782 shares, worth US$17.1M. Across 13 filings, CX Institutional increased the stake 7 time(s), trimmed it 4 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 64,782 shares valued at US$17.1M — an increase of 34,418 shares quarter over quarter.. Notable position changes include a 35% increase in Q3 2024 (shares fell 11% over the following quarter), a 46% trim in Q1 2026 (shares rose 4% over the following quarter), a 113% increase in Q3 2026 (shares rose 3% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 34.65K $5.40M New
Q4 2023 34.67K $5.43M Hold
Q1 2024 40.00K $6.33M Add
Q2 2024 36.31K $5.31M Reduce
Q3 2024 49.17K $7.97M Add
Q4 2024 58.31K $8.43M Add
Q1 2025 62.13K $10.30M Add
Q2 2025 64.09K $9.79M Add
Q3 2025 69.26K $12.84M Add
Q4 2025 65.44K $13.54M Reduce
Q1 2026 35.08K $8.58M Reduce
Q2 2026 30.36K $7.71M Reduce
Q3 2026 64.78K $17.15M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About JNJ and 13F data

JNJ (JOHNSON & JOHNSON) is a Health Care company. 33 other funds we track also report a position in JNJ — the largest reported positions include BlackRock Inc (US$53.87B), Vanguard Group (US$49.74B), VANGUARD CAPITAL MANAGEMENT LLC (US$39.93B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding JNJ

All JNJ fund holders →

FAQ

How long has CX Institutional held JNJ?

CX Institutional has disclosed JNJ holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is CX Institutional's current position in JNJ?

As of Q3 2026, CX Institutional holds 64.78K shares of JNJ (JOHNSON & JOHNSON), valued at $17.15M, representing 0.46% of its reported portfolio and ranking #48.

Has CX Institutional been buying or selling JNJ?

In the latest 13F filing (Q3 2026), CX Institutional increased its position in JNJ. The position peaked in Q3 2026 at 64.78K shares.

Which other funds hold JNJ?

Other major institutional holders of JNJ include BlackRock Inc, Vanguard Group, VANGUARD CAPITAL MANAGEMENT LLC, among 33 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.